Immunovant, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-53.4M | $-53.4M | $31.0K | $7.0M |
| FY2021 | $-83.3M | $-83.5M | $210.0K | $18.8M |
| FY2022 | $-106.1M | $-106.4M | $254.0K | $34.2M |
| FY2023 | $-188.2M | $-188.4M | $197.0K | $32.3M |
| FY2024 | $-214.2M | $-214.6M | $360.0K | $41.1M |